CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

Trial Identifier: D3612R00011
Sponsor: AstraZeneca
Start Date: December 2025
Primary Completion Date: February 2030
Study Completion Date: February 2030
Condition: Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

No locations posted.